Response to Poon et al. (DOI: 10.1089/neu.2018.6080): Acetylsalicylic Acid and Chronic Subdural Hematoma:Is It Really a Bad Couple? Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
Restricted accessLetterFirst published online January, 2020
Response to Poon et al. (DOI: 10.1089/neu.2018.6080): Acetylsalicylic Acid and Chronic Subdural Hematoma:Is It Really a Bad Couple? Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
PoonM.T.C., ReaC., KoliasA.G., and BrennanP.M. (2019). Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J. Neurotrauma, 2019. doi: 10.1089/neu.2018.6080 [Epub ahead of print].
2.
SzczygielskiJ., GundS.M., SchwerdtfegerK., SteudelW.I., and OertelJ. (2016). Factors affecting outcome in treatment of chronic subdural hematoma in icu patients: impact of anticoagulation. World Neurosurg. 92, 426–433.
3.
PatronoC., and RoccaB. (2012). Aspirin and other COX-1 inhibitors, in: Antiplatelet Agents. Handbook of Experimental Pharmacology, Vol. 210. GreseleP., BornG., PatronoC., and PageC. (eds). Springer: Berlin, Heidelberg, pps. 137–164.
4.
PrippA.H., and StanisicM. (2014). The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis. PLoS One, 9, e90149.
5.
StanisicM., LyngstadaasS.P., PrippA.H., AasenA.O., LindegaardK.F., IvanovicJ., IlstadE., KonglundA., SandellT., EllingsenO., and SaehleT. (2012). Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta neurochirurgica, 154, 113–120; discussion 120.
6.
FratiA., SalvatiM., MainieroF., IppolitiF., RocchiG., RacoA., CaroliE., CantoreG., and DelfiniR. (2004). Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J. Neurosurg. 100, 24–32.
7.
ThotakuraA.K. and MarabathinaN.R. (2015). Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg. 84, 1968–1972.
8.
Delgado-LopezP.D., Martin-VelascoV., Castilla-DiezJ.M., Rodriguez-SalazarA., Galacho-HarrieroA.M., and Fernandez-ArconadaO. (2009). Dexamethasone treatment in chronic subdural haematoma. Neurocirugia (Asturias, Spain) 20, 346–359.
9.
EmichS., RichlingB., McCoyM.R., Al-SchameriR.A., LingF., SunL., WangY., and HitzlW. (2014). The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma—the DRESH study: straightforward study protocol for a randomized controlled trial. Trials, 15, 6.
10.
WeigelR., HohensteinA., SchlickumL., WeissC., and SchillingL. (2007). Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery, 61, 788–792; discussion 792–783.
11.
WangD., LiT., TianY., WangS., JinC., WeiH., QuanW., WangJ., ChenJ., DongJ., JiangR., and ZhangJ. (2014). Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers. J. Neurol. Sci. 336, 237–242.
12.
JonesS., and KafetzK. (1999). A prospective study of chronic subdural haematomas in elderly patients. Age Ageing, 28, 519–521.
13.
MirandaL.B., BraxtonE., HobbsJ., and QuigleyM.R. (2011). Chronic subdural hematoma in the elderly: not a benign disease. J. Neurosurg. 114, 72–76.
14.
DumontT.M., RughaniA.I., GoeckesT., and TranmerB.I. (2013). Chronic subdural hematoma: a sentinel health event. World Neurosurg. 80, 889–892.
15.
GrossB.A., Rosalind LaiP.M., FrerichsK.U., and DuR. (2014). Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg. 82, 1127–1130.
16.
FortunaG.R., MuellerE.W., JamesL.E., ShutterL.A., and ButlerK.L. (2008). The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery, 144, 598–603; discussion 603–595.
